Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
RIZATRIPTANBENZOAAT SAMENSTELLING overeenkomend met ; RIZATRIPTAN
Merck Sharp & Dohme B.V. Waarderweg 39 2031 BN HAARLEM
N02CC04
RIZATRIPTANBENZOAAT COMPOSITION corresponding to ; RIZATRIPTAN
Orodispergeerbare tablet
ASPARTAAM (E 951) ; DEXTRINE ; GELATINE (E 441) ; GLYCINE (E 640) ; MALTODEXTRINE ; MANNITOL (D-) (E 421) ; PEPERMUNTOLIE ; PEPERMUNTSMAAKSTOF,
Oraal gebruik
Rizatriptan
Hulpstoffen: ASPARTAAM (E 951); DEXTRINE; GELATINE (E 441); GLYCINE (E 640); MALTODEXTRINE; MANNITOL (D-) (E 421); PEPERMUNTOLIE; PEPERMUNTSMAAKSTOF;
2013-07-19
1 PACKAGE LEAFLET: INFORMATION FOR THE USER RIZATRIPTAN MSD 5 MG, ORODISPERGEERBARE TABLETTEN RIZATRIPTAN MSD 10 MG, ORODISPERGEERBARE TABLETTEN RIZATRIPTAN READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What RIZATRIPTAN is and what it is used for 2. What you need to know before you take RIZATRIPTAN 3. How to take RIZATRIPTAN 4. Possible side effects 5. How to store RIZATRIPTAN 6. Contents of the pack and other information 1. WHAT RIZATRIPTAN IS AND WHAT IT IS USED FOR RIZATRIPTAN belongs to a class of medicines called selective serotonin 5-HT 1B/1D receptor agonists. RIZATRIPTAN is used to treat the headache phase of the migraine attack in adults. Treatment with RIZATRIPTAN: Reduces swelling of blood vessels surrounding the brain. This swelling results in the headache pain of a migraine attack. _ _ 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE RIZATRIPTAN_ _ DO NOT TAKE RIZATRIPTAN_ _IF: - you are allergic to rizatriptan benzoate or any of the other ingredients of this medicine (listed in section 6) - you have moderately severe or severe high blood pressure, or mild high blood pressure that is not controlled by medication - you have or have ever had heart problems including heart attack or pain on the chest (angina) or you have experienced heart disease related signs - you have severe liver or severe kidney problems - you have had a stroke (cerebrovascular accident CVA) or mini stroke (transient ischaemic attack TIA) - you have blockage problems with your arteries (peripheral vascular disease) - you are tak Lees het volledige document
1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Rizatriptan MSD 5 mg, orodispergeerbare tabletten _ _ Rizatriptan MSD 10 mg, orodispergeerbare tabletten 2. QUALITATIVE AND QUANTITATIVE COMPOSITION RIZATRIPTAN MSD 5 MG ORODISPERGEERBARE TABLETTEN Each oral lyophilisate contains 7.265 mg of rizatriptan benzoate (corresponding to 5 mg of the rizatriptan). Excipient(s) with known effect Aspartame (E951) 1.88 mg in the 5 mg oral lyophilisate. RIZATRIPTAN MSD 10 MG ORODISPERGEERBARE TABLETTEN Each oral lyophilisate contains 14.53 mg of rizatriptan benzoate (corresponding to 10 mg of the rizatriptan). Excipient(s) with known effect Aspartame (E951) 3.75 mg in the 10 mg oral lyophilisate. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Oral lyophilisate RIZATRIPTAN MSD 5 MG ORODISPERGEERBARE TABLETTEN 5 mg oral lyophilisates are white to off-white, round with a modified triangle on one side, with a peppermint flavour. RIZATRIPTAN MSD 10 MG ORODISPERGEERBARE TABLETTEN 10 mg oral lyophilisates are white to off-white, round with a modified square on one side, with a peppermint flavour. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Acute treatment of the headache phase of migraine attacks with or without aura in adults. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Method of administration _ _ RIZATRIPTAN oral lyophilisates should not be used prophylactically. RIZATRIPTAN oral lyophilisates need not be taken with liquid. The oral lyophilisate is packaged in a blister within an outer aluminium sachet. Patients should be instructed not to remove the blister from the outer sachet until just prior to dosing. The blister pack 2 should then be peeled open with dry hands and the oral lyophilisate placed on the tongue, where it will dissolve and be swallowed with the saliva. RIZATRIPTAN is also available as a tablet formulation. The oral lyophilisate can be used in situations in which liquids are not available, or to avoid the nausea and vomiting that may accompany the ingestion of ta Lees het volledige document